5G6-23170-31565
3 vaccinations
4 coded responses
22 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 618 / IL
- Registered
- 2021-02-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-02
Registered in v-safe
-
2021-02-02
Dose 1 — Pfizer-BioNTech
- 2021-02-02
- 2021-02-04
- 2021-02-05
- 2021-02-08
- 2021-02-11
- 2021-02-16
-
2021-02-23
Dose 2 — Pfizer-BioNTech
-
2021-02-23
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Chills, Muscle or body achesAdult check-in
-
2021-02-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-26
- 2021-02-27
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-02
Survey response — day 7, dose 2MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Fever · Fatigue or tirednessFree text: Runny nose, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-09
-
2021-03-18
Survey response — day 21, dose 2MedDRA: Chills, Exposure to SARS-CoV-2 — Feeling: GoodFree text: I was exposed to the virus. Three days later, I had chills, which lasted for 48 hours.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-23
- 2021-04-01
- 2021-04-08
- 2021-05-25
- 2021-08-24
-
2022-01-18
Dose 3 — Other-Unknown
-
2022-02-23
Survey response — 12 months, dose 2MedDRA: Chills, Diarrhoea, Headache, Motion sickness, Office visit, Parosmia, Pyrexia, SARS-CoV-2 test negative, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: From 02/11-02/13/22, I had intense vomiting, diarrhea, chills, fever, headache, motion sickness, & sensitivity to smell. I never lost my sense of taste or smell. I received a negative COVID test, proctored by Campustown Urgent Care in (b)(6)MedDRA releases: 2024-11 · check-in free text available
-
2022-07-21
Survey response — 6 months, dose 3MedDRA: Pregnancy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Morning sickness due to pregnancyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-02 | Pfizer-BioNTech | |
| 2 | 2021-02-23 | Pfizer-BioNTech | |
| 3 | 2022-01-18 | Other-Unknown | No |
Free text
Release 4 — day 7, dose 2
Systemic reaction (other): Runny nose, sore throat
Release 5 — day 21, dose 2
Symptoms: I was exposed to the virus. Three days later, I had chills, which lasted for 48 hours.
Release 11 — 12 months, dose 2
Symptoms: From 02/11-02/13/22, I had intense vomiting, diarrhea, chills, fever, headache, motion sickness, & sensitivity to smell. I never lost my sense of taste or smell. I received a negative COVID test, proctored by Campustown Urgent Care in (b)(6)
redacted (b)(6)
Release 12 — 6 months, dose 3
Symptoms: Morning sickness due to pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Motion sickness | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Parosmia | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release